nodes	percent_of_prediction	percent_of_DWPC	metapath
Prochlorperazine—DRD3—attention deficit hyperactivity disorder	0.489	0.591	CbGaD
Prochlorperazine—DRD2—attention deficit hyperactivity disorder	0.338	0.409	CbGaD
Prochlorperazine—CHRM2—forebrain—attention deficit hyperactivity disorder	0.00113	0.0674	CbGeAlD
Prochlorperazine—HTR2C—forebrain—attention deficit hyperactivity disorder	0.00109	0.065	CbGeAlD
Prochlorperazine—DRD3—nervous system—attention deficit hyperactivity disorder	0.00107	0.0634	CbGeAlD
Prochlorperazine—DRD3—central nervous system—attention deficit hyperactivity disorder	0.00103	0.0611	CbGeAlD
Prochlorperazine—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.000959	0.057	CbGeAlD
Prochlorperazine—DRD2—forebrain—attention deficit hyperactivity disorder	0.000831	0.0494	CbGeAlD
Prochlorperazine—DRD3—brain—attention deficit hyperactivity disorder	0.000815	0.0485	CbGeAlD
Prochlorperazine—HTR2C—midbrain—attention deficit hyperactivity disorder	0.000722	0.0429	CbGeAlD
Prochlorperazine—HRH1—forebrain—attention deficit hyperactivity disorder	0.000656	0.039	CbGeAlD
Prochlorperazine—CHRM2—nervous system—attention deficit hyperactivity disorder	0.000615	0.0366	CbGeAlD
Prochlorperazine—HTR2C—nervous system—attention deficit hyperactivity disorder	0.000593	0.0353	CbGeAlD
Prochlorperazine—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.000592	0.0352	CbGeAlD
Prochlorperazine—HTR2C—central nervous system—attention deficit hyperactivity disorder	0.000571	0.034	CbGeAlD
Prochlorperazine—DRD2—midbrain—attention deficit hyperactivity disorder	0.000549	0.0326	CbGeAlD
Prochlorperazine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000499	0.0297	CbGeAlD
Prochlorperazine—CHRM2—brain—attention deficit hyperactivity disorder	0.00047	0.028	CbGeAlD
Prochlorperazine—HTR2C—brain—attention deficit hyperactivity disorder	0.000453	0.027	CbGeAlD
Prochlorperazine—DRD2—nervous system—attention deficit hyperactivity disorder	0.000451	0.0268	CbGeAlD
Prochlorperazine—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000434	0.0258	CbGeAlD
Prochlorperazine—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000425	0.0253	CbGeAlD
Prochlorperazine—HRH1—nervous system—attention deficit hyperactivity disorder	0.000356	0.0212	CbGeAlD
Prochlorperazine—DRD2—brain—attention deficit hyperactivity disorder	0.000345	0.0205	CbGeAlD
Prochlorperazine—HRH1—central nervous system—attention deficit hyperactivity disorder	0.000343	0.0204	CbGeAlD
Prochlorperazine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000275	0.0164	CbGeAlD
Prochlorperazine—HRH1—brain—attention deficit hyperactivity disorder	0.000272	0.0162	CbGeAlD
Prochlorperazine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000271	0.0161	CbGeAlD
Prochlorperazine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000265	0.0158	CbGeAlD
Prochlorperazine—Zuclopenthixol—DRD5—attention deficit hyperactivity disorder	0.000262	0.0241	CrCbGaD
Prochlorperazine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000261	0.0155	CbGeAlD
Prochlorperazine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000255	0.0152	CbGeAlD
Prochlorperazine—Aripiprazole—DRD5—attention deficit hyperactivity disorder	0.000242	0.0223	CrCbGaD
Prochlorperazine—Aripiprazole—ADRA2C—attention deficit hyperactivity disorder	0.000228	0.021	CrCbGaD
Prochlorperazine—CYP2D6—brain—attention deficit hyperactivity disorder	0.000207	0.0123	CbGeAlD
Prochlorperazine—Mianserin—ADRA2C—attention deficit hyperactivity disorder	0.000184	0.0169	CrCbGaD
Prochlorperazine—Acetophenazine—DRD1—attention deficit hyperactivity disorder	0.000179	0.0165	CrCbGaD
Prochlorperazine—Methotrimeprazine—DRD5—attention deficit hyperactivity disorder	0.00016	0.0148	CrCbGaD
Prochlorperazine—Propericiazine—DRD1—attention deficit hyperactivity disorder	0.000158	0.0146	CrCbGaD
Prochlorperazine—Loxapine—DRD5—attention deficit hyperactivity disorder	0.000155	0.0143	CrCbGaD
Prochlorperazine—Methotrimeprazine—ADRA2C—attention deficit hyperactivity disorder	0.000151	0.0139	CrCbGaD
Prochlorperazine—Quetiapine—DRD5—attention deficit hyperactivity disorder	0.000151	0.0139	CrCbGaD
Prochlorperazine—Propericiazine—ADRA2A—attention deficit hyperactivity disorder	0.000147	0.0135	CrCbGaD
Prochlorperazine—Loxapine—ADRA2C—attention deficit hyperactivity disorder	0.000146	0.0134	CrCbGaD
Prochlorperazine—Quetiapine—ADRA2C—attention deficit hyperactivity disorder	0.000143	0.0131	CrCbGaD
Prochlorperazine—Domperidone—DRD3—attention deficit hyperactivity disorder	0.000138	0.0127	CrCbGaD
Prochlorperazine—Clozapine—HRH3—attention deficit hyperactivity disorder	0.000134	0.0124	CrCbGaD
Prochlorperazine—Acetophenazine—DRD2—attention deficit hyperactivity disorder	0.000126	0.0116	CrCbGaD
Prochlorperazine—Aripiprazole—DRD4—attention deficit hyperactivity disorder	0.000124	0.0114	CrCbGaD
Prochlorperazine—Clozapine—ADRA2C—attention deficit hyperactivity disorder	0.000123	0.0113	CrCbGaD
Prochlorperazine—Chlorpromazine—DRD5—attention deficit hyperactivity disorder	0.000122	0.0113	CrCbGaD
Prochlorperazine—Zuclopenthixol—DRD1—attention deficit hyperactivity disorder	0.000113	0.0104	CrCbGaD
Prochlorperazine—Aripiprazole—HTR1B—attention deficit hyperactivity disorder	0.00011	0.0101	CrCbGaD
Prochlorperazine—Triflupromazine—DRD1—attention deficit hyperactivity disorder	0.00011	0.0101	CrCbGaD
Prochlorperazine—Nefazodone—SLC6A3—attention deficit hyperactivity disorder	0.000107	0.00983	CrCbGaD
Prochlorperazine—Aripiprazole—DRD3—attention deficit hyperactivity disorder	0.000107	0.00982	CrCbGaD
Prochlorperazine—Zuclopenthixol—ADRA2A—attention deficit hyperactivity disorder	0.000105	0.00969	CrCbGaD
Prochlorperazine—Aripiprazole—DRD1—attention deficit hyperactivity disorder	0.000105	0.00964	CrCbGaD
Prochlorperazine—Nefazodone—ADRA2A—attention deficit hyperactivity disorder	0.000105	0.00964	CrCbGaD
Prochlorperazine—Acepromazine—DRD1—attention deficit hyperactivity disorder	0.000102	0.00935	CrCbGaD
Prochlorperazine—Thioproperazine—DRD1—attention deficit hyperactivity disorder	9.93e-05	0.00914	CrCbGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	9.92e-05	0.000684	CbGpPWpGaD
Prochlorperazine—Mesoridazine—DRD3—attention deficit hyperactivity disorder	9.82e-05	0.00904	CrCbGaD
Prochlorperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	9.77e-05	0.000674	CbGpPWpGaD
Prochlorperazine—Thiothixene—DRD1—attention deficit hyperactivity disorder	9.77e-05	0.00899	CrCbGaD
Prochlorperazine—Pipotiazine—DRD1—attention deficit hyperactivity disorder	9.77e-05	0.00899	CrCbGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	9.76e-05	0.000673	CbGpPWpGaD
Prochlorperazine—Aripiprazole—ADRA2A—attention deficit hyperactivity disorder	9.73e-05	0.00896	CrCbGaD
Prochlorperazine—DRD3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	9.72e-05	0.00067	CbGpPWpGaD
Prochlorperazine—Trazodone—ADRA2A—attention deficit hyperactivity disorder	9.69e-05	0.00892	CrCbGaD
Prochlorperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	9.65e-05	0.000665	CbGpPWpGaD
Prochlorperazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	9.64e-05	0.000664	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	9.62e-05	0.000663	CbGpPWpGaD
Prochlorperazine—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	9.6e-05	0.000662	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	9.6e-05	0.000662	CbGpPWpGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	9.6e-05	0.000662	CbGpPWpGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	9.59e-05	0.000661	CbGpPWpGaD
Prochlorperazine—Propiomazine—DRD4—attention deficit hyperactivity disorder	9.59e-05	0.00883	CrCbGaD
Prochlorperazine—Domperidone—DRD2—attention deficit hyperactivity disorder	9.56e-05	0.0088	CrCbGaD
Prochlorperazine—HTR2C—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	9.53e-05	0.000657	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	9.5e-05	0.000655	CbGpPWpGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	9.48e-05	0.000653	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	9.44e-05	0.000651	CbGpPWpGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	9.44e-05	0.000651	CbGpPWpGaD
Prochlorperazine—HRH1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	9.34e-05	0.000644	CbGpPWpGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	9.32e-05	0.000643	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	9.31e-05	0.000642	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	9.29e-05	0.000641	CbGpPWpGaD
Prochlorperazine—Thiothixene—ADRA2A—attention deficit hyperactivity disorder	9.08e-05	0.00836	CrCbGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	9.07e-05	0.000625	CbGpPWpGaD
Prochlorperazine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	8.95e-05	0.000617	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	8.95e-05	0.000617	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	8.89e-05	0.000613	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	8.86e-05	0.000611	CbGpPWpGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	8.83e-05	0.000609	CbGpPWpGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	8.69e-05	0.000599	CbGpPWpGaD
Prochlorperazine—Cyamemazine—HTR2A—attention deficit hyperactivity disorder	8.61e-05	0.00793	CrCbGaD
Prochlorperazine—Mianserin—DRD3—attention deficit hyperactivity disorder	8.6e-05	0.00792	CrCbGaD
Prochlorperazine—Fluphenazine—DRD3—attention deficit hyperactivity disorder	8.6e-05	0.00792	CrCbGaD
Prochlorperazine—HTR2C—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	8.58e-05	0.000591	CbGpPWpGaD
Prochlorperazine—Fluphenazine—DRD1—attention deficit hyperactivity disorder	8.44e-05	0.00777	CrCbGaD
Prochlorperazine—HTR2C—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	8.43e-05	0.000581	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	8.41e-05	0.00058	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	8.37e-05	0.000577	CbGpPWpGaD
Prochlorperazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	8.35e-05	0.000576	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	8.33e-05	0.000574	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	8.33e-05	0.000574	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	8.26e-05	0.000569	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	8.24e-05	0.000568	CbGpPWpGaD
Prochlorperazine—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	8.23e-05	0.000567	CbGpPWpGaD
Prochlorperazine—Methotrimeprazine—DRD4—attention deficit hyperactivity disorder	8.2e-05	0.00755	CrCbGaD
Prochlorperazine—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	8.12e-05	0.00056	CbGpPWpGaD
Prochlorperazine—Propiomazine—DRD1—attention deficit hyperactivity disorder	8.12e-05	0.00748	CrCbGaD
Prochlorperazine—HTR2C—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	8.07e-05	0.000556	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	8.01e-05	0.000552	CbGpPWpGaD
Prochlorperazine—Mianserin—SLC6A3—attention deficit hyperactivity disorder	8e-05	0.00737	CrCbGaD
Prochlorperazine—Zuclopenthixol—DRD2—attention deficit hyperactivity disorder	7.99e-05	0.00735	CrCbGaD
Prochlorperazine—Nefazodone—SLC6A4—attention deficit hyperactivity disorder	7.98e-05	0.00735	CrCbGaD
Prochlorperazine—Loxapine—DRD4—attention deficit hyperactivity disorder	7.92e-05	0.00729	CrCbGaD
Prochlorperazine—HRH1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	7.86e-05	0.000542	CbGpPWpGaD
Prochlorperazine—Mianserin—ADRA2A—attention deficit hyperactivity disorder	7.84e-05	0.00722	CrCbGaD
Prochlorperazine—Fluphenazine—ADRA2A—attention deficit hyperactivity disorder	7.84e-05	0.00722	CrCbGaD
Prochlorperazine—DRD2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	7.84e-05	0.000541	CbGpPWpGaD
Prochlorperazine—Chlorprothixene—DRD3—attention deficit hyperactivity disorder	7.83e-05	0.00721	CrCbGaD
Prochlorperazine—DRD2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	7.82e-05	0.000539	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	7.76e-05	0.000535	CbGpPWpGaD
Prochlorperazine—Triflupromazine—DRD2—attention deficit hyperactivity disorder	7.74e-05	0.00713	CrCbGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	7.73e-05	0.000533	CbGpPWpGaD
Prochlorperazine—Quetiapine—DRD4—attention deficit hyperactivity disorder	7.73e-05	0.00712	CrCbGaD
Prochlorperazine—HRH1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	7.7e-05	0.000531	CbGpPWpGaD
Prochlorperazine—Chlorprothixene—DRD1—attention deficit hyperactivity disorder	7.69e-05	0.00708	CrCbGaD
Prochlorperazine—HRH1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	7.67e-05	0.000529	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	7.58e-05	0.000522	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	7.57e-05	0.000522	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	7.55e-05	0.000521	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	7.44e-05	0.000513	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	7.43e-05	0.000512	CbGpPWpGaD
Prochlorperazine—Aripiprazole—SLC6A4—attention deficit hyperactivity disorder	7.42e-05	0.00683	CrCbGaD
Prochlorperazine—Trazodone—SLC6A4—attention deficit hyperactivity disorder	7.39e-05	0.0068	CrCbGaD
Prochlorperazine—Aripiprazole—DRD2—attention deficit hyperactivity disorder	7.38e-05	0.0068	CrCbGaD
Prochlorperazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	7.35e-05	0.000507	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	7.35e-05	0.000507	CbGpPWpGaD
Prochlorperazine—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	7.33e-05	0.000505	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	7.31e-05	0.000504	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	7.31e-05	0.000504	CbGpPWpGaD
Prochlorperazine—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	7.27e-05	0.000501	CbGpPWpGaD
Prochlorperazine—Thioridazine—DRD1—attention deficit hyperactivity disorder	7.27e-05	0.0067	CrCbGaD
Prochlorperazine—DRD2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	7.27e-05	0.000501	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	7.25e-05	0.0005	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	7.23e-05	0.000498	CbGpPWpGaD
Prochlorperazine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	7.22e-05	0.000497	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	7.22e-05	0.000497	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	7.19e-05	0.000496	CbGpPWpGaD
Prochlorperazine—Clomipramine—ADRA2A—attention deficit hyperactivity disorder	7.17e-05	0.00661	CrCbGaD
Prochlorperazine—Acepromazine—DRD2—attention deficit hyperactivity disorder	7.16e-05	0.00659	CrCbGaD
Prochlorperazine—HRH1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	7.14e-05	0.000492	CbGpPWpGaD
Prochlorperazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	7.13e-05	0.000492	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	7.12e-05	0.000491	CbGpPWpGaD
Prochlorperazine—Promazine—DRD4—attention deficit hyperactivity disorder	7.11e-05	0.00655	CrCbGaD
Prochlorperazine—DRD3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	7.1e-05	0.00049	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	7.1e-05	0.00049	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	7.1e-05	0.000489	CbGpPWpGaD
Prochlorperazine—Methotrimeprazine—DRD3—attention deficit hyperactivity disorder	7.07e-05	0.00651	CrCbGaD
Prochlorperazine—Loxapine—HTR1B—attention deficit hyperactivity disorder	7.04e-05	0.00648	CrCbGaD
Prochlorperazine—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	7.02e-05	0.000484	CbGpPWpGaD
Prochlorperazine—Thioproperazine—DRD2—attention deficit hyperactivity disorder	7e-05	0.00644	CrCbGaD
Prochlorperazine—HRH1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	6.99e-05	0.000482	CbGpPWpGaD
Prochlorperazine—Methotrimeprazine—DRD1—attention deficit hyperactivity disorder	6.94e-05	0.00639	CrCbGaD
Prochlorperazine—Thiothixene—DRD2—attention deficit hyperactivity disorder	6.89e-05	0.00634	CrCbGaD
Prochlorperazine—Pipotiazine—DRD2—attention deficit hyperactivity disorder	6.89e-05	0.00634	CrCbGaD
Prochlorperazine—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	6.88e-05	0.000474	CbGpPWpGaD
Prochlorperazine—Quetiapine—HTR1B—attention deficit hyperactivity disorder	6.87e-05	0.00632	CrCbGaD
Prochlorperazine—Loxapine—DRD3—attention deficit hyperactivity disorder	6.83e-05	0.00629	CrCbGaD
Prochlorperazine—Mesoridazine—DRD2—attention deficit hyperactivity disorder	6.8e-05	0.00626	CrCbGaD
Prochlorperazine—Thioridazine—ADRA2A—attention deficit hyperactivity disorder	6.76e-05	0.00622	CrCbGaD
Prochlorperazine—HRH1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	6.72e-05	0.000463	CbGpPWpGaD
Prochlorperazine—Loxapine—DRD1—attention deficit hyperactivity disorder	6.71e-05	0.00617	CrCbGaD
Prochlorperazine—Perphenazine—DRD1—attention deficit hyperactivity disorder	6.67e-05	0.00615	CrCbGaD
Prochlorperazine—Quetiapine—DRD3—attention deficit hyperactivity disorder	6.67e-05	0.00614	CrCbGaD
Prochlorperazine—Clozapine—DRD4—attention deficit hyperactivity disorder	6.65e-05	0.00612	CrCbGaD
Prochlorperazine—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	6.61e-05	0.000456	CbGpPWpGaD
Prochlorperazine—Quetiapine—DRD1—attention deficit hyperactivity disorder	6.55e-05	0.00603	CrCbGaD
Prochlorperazine—DRD3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	6.53e-05	0.00045	CbGpPWpGaD
Prochlorperazine—Methotrimeprazine—ADRA2A—attention deficit hyperactivity disorder	6.45e-05	0.00594	CrCbGaD
Prochlorperazine—DRD3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	6.45e-05	0.000445	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	6.4e-05	0.000441	CbGpPWpGaD
Prochlorperazine—Loxapine—SLC6A3—attention deficit hyperactivity disorder	6.36e-05	0.00585	CrCbGaD
Prochlorperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	6.3e-05	0.000434	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	6.29e-05	0.000433	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	6.27e-05	0.000432	CbGpPWpGaD
Prochlorperazine—Chlorpromazine—DRD4—attention deficit hyperactivity disorder	6.26e-05	0.00576	CrCbGaD
Prochlorperazine—Loxapine—ADRA2A—attention deficit hyperactivity disorder	6.23e-05	0.00574	CrCbGaD
Prochlorperazine—DRD3—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	6.21e-05	0.000428	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	6.21e-05	0.000428	CbGpPWpGaD
Prochlorperazine—Perphenazine—ADRA2A—attention deficit hyperactivity disorder	6.2e-05	0.00571	CrCbGaD
Prochlorperazine—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	6.19e-05	0.000426	CbGpPWpGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	6.18e-05	0.000426	CbGpPWpGaD
Prochlorperazine—Zuclopenthixol—HTR2A—attention deficit hyperactivity disorder	6.17e-05	0.00568	CrCbGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	6.16e-05	0.000425	CbGpPWpGaD
Prochlorperazine—Nefazodone—HTR2A—attention deficit hyperactivity disorder	6.14e-05	0.00565	CrCbGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	6.08e-05	0.000419	CbGpPWpGaD
Prochlorperazine—Quetiapine—ADRA2A—attention deficit hyperactivity disorder	6.08e-05	0.0056	CrCbGaD
Prochlorperazine—Promazine—DRD1—attention deficit hyperactivity disorder	6.02e-05	0.00554	CrCbGaD
Prochlorperazine—Mianserin—SLC6A4—attention deficit hyperactivity disorder	5.98e-05	0.00551	CrCbGaD
Prochlorperazine—Mianserin—DRD2—attention deficit hyperactivity disorder	5.95e-05	0.00548	CrCbGaD
Prochlorperazine—Fluphenazine—DRD2—attention deficit hyperactivity disorder	5.95e-05	0.00548	CrCbGaD
Prochlorperazine—Clozapine—HTR1B—attention deficit hyperactivity disorder	5.91e-05	0.00544	CrCbGaD
Prochlorperazine—Desipramine—SLC6A3—attention deficit hyperactivity disorder	5.89e-05	0.00542	CrCbGaD
Prochlorperazine—DRD3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	5.77e-05	0.000398	CbGpPWpGaD
Prochlorperazine—Clozapine—DRD3—attention deficit hyperactivity disorder	5.74e-05	0.00528	CrCbGaD
Prochlorperazine—Propiomazine—DRD2—attention deficit hyperactivity disorder	5.72e-05	0.00527	CrCbGaD
Prochlorperazine—Aripiprazole—HTR2A—attention deficit hyperactivity disorder	5.7e-05	0.00525	CrCbGaD
Prochlorperazine—Trazodone—HTR2A—attention deficit hyperactivity disorder	5.68e-05	0.00523	CrCbGaD
Prochlorperazine—HTR2C—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	5.66e-05	0.00039	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	5.64e-05	0.000389	CbGpPWpGaD
Prochlorperazine—Clozapine—DRD1—attention deficit hyperactivity disorder	5.63e-05	0.00518	CrCbGaD
Prochlorperazine—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	5.63e-05	0.000388	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	5.61e-05	0.000387	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	5.59e-05	0.000386	CbGpPWpGaD
Prochlorperazine—Promazine—ADRA2A—attention deficit hyperactivity disorder	5.59e-05	0.00515	CrCbGaD
Prochlorperazine—Acepromazine—HTR2A—attention deficit hyperactivity disorder	5.53e-05	0.00509	CrCbGaD
Prochlorperazine—DRD3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	5.5e-05	0.000379	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	5.5e-05	0.000379	CbGpPWpGaD
Prochlorperazine—Clomipramine—SLC6A4—attention deficit hyperactivity disorder	5.47e-05	0.00504	CrCbGaD
Prochlorperazine—DRD2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	5.44e-05	0.000375	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	5.43e-05	0.000375	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	5.43e-05	0.000374	CbGpPWpGaD
Prochlorperazine—Chlorprothixene—DRD2—attention deficit hyperactivity disorder	5.42e-05	0.00499	CrCbGaD
Prochlorperazine—Thioproperazine—HTR2A—attention deficit hyperactivity disorder	5.41e-05	0.00498	CrCbGaD
Prochlorperazine—Chlorpromazine—DRD3—attention deficit hyperactivity disorder	5.39e-05	0.00497	CrCbGaD
Prochlorperazine—DRD3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	5.39e-05	0.000372	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	5.38e-05	0.000371	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	5.34e-05	0.000368	CbGpPWpGaD
Prochlorperazine—Thiothixene—HTR2A—attention deficit hyperactivity disorder	5.32e-05	0.0049	CrCbGaD
Prochlorperazine—Pipotiazine—HTR2A—attention deficit hyperactivity disorder	5.32e-05	0.0049	CrCbGaD
Prochlorperazine—Chlorpromazine—DRD1—attention deficit hyperactivity disorder	5.3e-05	0.00488	CrCbGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	5.25e-05	0.000362	CbGpPWpGaD
Prochlorperazine—Mesoridazine—HTR2A—attention deficit hyperactivity disorder	5.25e-05	0.00484	CrCbGaD
Prochlorperazine—DRD3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	5.24e-05	0.000361	CbGpPWpGaD
Prochlorperazine—Clozapine—ADRA2A—attention deficit hyperactivity disorder	5.23e-05	0.00482	CrCbGaD
Prochlorperazine—Thioridazine—DRD2—attention deficit hyperactivity disorder	5.13e-05	0.00472	CrCbGaD
Prochlorperazine—DRD3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	5.06e-05	0.000349	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	5.01e-05	0.000345	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	5e-05	0.000345	CbGpPWpGaD
Prochlorperazine—Imipramine—SLC6A3—attention deficit hyperactivity disorder	4.99e-05	0.0046	CrCbGaD
Prochlorperazine—DRD3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.99e-05	0.000344	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.94e-05	0.00034	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	4.93e-05	0.00034	CbGpPWpGaD
Prochlorperazine—Chlorpromazine—ADRA2A—attention deficit hyperactivity disorder	4.92e-05	0.00453	CrCbGaD
Prochlorperazine—HRH1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.91e-05	0.000338	CbGpPWpGaD
Prochlorperazine—Methotrimeprazine—DRD2—attention deficit hyperactivity disorder	4.9e-05	0.00451	CrCbGaD
Prochlorperazine—HTR2C—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.89e-05	0.000337	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.87e-05	0.000335	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.85e-05	0.000334	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.85e-05	0.000334	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.83e-05	0.000333	CbGpPWpGaD
Prochlorperazine—Promethazine—DRD2—attention deficit hyperactivity disorder	4.82e-05	0.00444	CrCbGaD
Prochlorperazine—DRD2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.8e-05	0.000331	CbGpPWpGaD
Prochlorperazine—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	4.79e-05	0.00033	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.77e-05	0.000329	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.77e-05	0.000329	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.76e-05	0.000328	CbGpPWpGaD
Prochlorperazine—Trifluoperazine—DRD2—attention deficit hyperactivity disorder	4.76e-05	0.00438	CrCbGaD
Prochlorperazine—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	4.76e-05	0.000328	CbGpPWpGaD
Prochlorperazine—DRD2—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	4.75e-05	0.000328	CbGpPWpGaD
Prochlorperazine—Loxapine—SLC6A4—attention deficit hyperactivity disorder	4.75e-05	0.00438	CrCbGaD
Prochlorperazine—DRD2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.75e-05	0.000328	CbGpPWpGaD
Prochlorperazine—Loxapine—DRD2—attention deficit hyperactivity disorder	4.73e-05	0.00435	CrCbGaD
Prochlorperazine—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	4.72e-05	0.000326	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.71e-05	0.000325	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.71e-05	0.000324	CbGpPWpGaD
Prochlorperazine—Perphenazine—DRD2—attention deficit hyperactivity disorder	4.71e-05	0.00433	CrCbGaD
Prochlorperazine—HTR2C—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.67e-05	0.000322	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.67e-05	0.000322	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.63e-05	0.000319	CbGpPWpGaD
Prochlorperazine—Quetiapine—DRD2—attention deficit hyperactivity disorder	4.61e-05	0.00425	CrCbGaD
Prochlorperazine—Mianserin—HTR2A—attention deficit hyperactivity disorder	4.6e-05	0.00423	CrCbGaD
Prochlorperazine—Fluphenazine—HTR2A—attention deficit hyperactivity disorder	4.6e-05	0.00423	CrCbGaD
Prochlorperazine—DRD3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	4.59e-05	0.000317	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.59e-05	0.000316	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.55e-05	0.000313	CbGpPWpGaD
Prochlorperazine—Propiomazine—HTR2A—attention deficit hyperactivity disorder	4.42e-05	0.00407	CrCbGaD
Prochlorperazine—DRD2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.42e-05	0.000305	CbGpPWpGaD
Prochlorperazine—Desipramine—SLC6A4—attention deficit hyperactivity disorder	4.4e-05	0.00405	CrCbGaD
Prochlorperazine—HTR2C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	4.4e-05	0.000303	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	4.38e-05	0.000302	CbGpPWpGaD
Prochlorperazine—Desipramine—DRD2—attention deficit hyperactivity disorder	4.38e-05	0.00403	CrCbGaD
Prochlorperazine—HRH1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.34e-05	0.000299	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.33e-05	0.000298	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.31e-05	0.000297	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.29e-05	0.000296	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.28e-05	0.000295	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	4.27e-05	0.000295	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.27e-05	0.000294	CbGpPWpGaD
Prochlorperazine—Promazine—DRD2—attention deficit hyperactivity disorder	4.24e-05	0.00391	CrCbGaD
Prochlorperazine—HRH1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.24e-05	0.000292	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.22e-05	0.000291	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.21e-05	0.00029	CbGpPWpGaD
Prochlorperazine—Clomipramine—HTR2A—attention deficit hyperactivity disorder	4.21e-05	0.00387	CrCbGaD
Prochlorperazine—DRD2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.21e-05	0.00029	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.2e-05	0.00029	CbGpPWpGaD
Prochlorperazine—Chlorprothixene—HTR2A—attention deficit hyperactivity disorder	4.19e-05	0.00386	CrCbGaD
Prochlorperazine—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.17e-05	0.000287	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.15e-05	0.000286	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.15e-05	0.000286	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.13e-05	0.000285	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.13e-05	0.000285	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.13e-05	0.000285	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.13e-05	0.000284	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.08e-05	0.000281	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.06e-05	0.00028	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.06e-05	0.00028	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.05e-05	0.000279	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.01e-05	0.000277	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.01e-05	0.000277	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.99e-05	0.000275	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.98e-05	0.000274	CbGpPWpGaD
Prochlorperazine—Clozapine—DRD2—attention deficit hyperactivity disorder	3.97e-05	0.00365	CrCbGaD
Prochlorperazine—Thioridazine—HTR2A—attention deficit hyperactivity disorder	3.96e-05	0.00365	CrCbGaD
Prochlorperazine—HRH1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.94e-05	0.000272	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.88e-05	0.000268	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.88e-05	0.000267	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.82e-05	0.000263	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.81e-05	0.000263	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.81e-05	0.000263	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.8e-05	0.000262	CbGpPWpGaD
Prochlorperazine—Methotrimeprazine—HTR2A—attention deficit hyperactivity disorder	3.78e-05	0.00348	CrCbGaD
Prochlorperazine—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.77e-05	0.00026	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.75e-05	0.000259	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.75e-05	0.000258	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.74e-05	0.000258	CbGpPWpGaD
Prochlorperazine—Imipramine—SLC6A4—attention deficit hyperactivity disorder	3.73e-05	0.00344	CrCbGaD
Prochlorperazine—Chlorpromazine—DRD2—attention deficit hyperactivity disorder	3.73e-05	0.00344	CrCbGaD
Prochlorperazine—Promethazine—HTR2A—attention deficit hyperactivity disorder	3.73e-05	0.00343	CrCbGaD
Prochlorperazine—Imipramine—DRD2—attention deficit hyperactivity disorder	3.71e-05	0.00342	CrCbGaD
Prochlorperazine—HRH1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.7e-05	0.000255	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.69e-05	0.000254	CbGpPWpGaD
Prochlorperazine—Trifluoperazine—HTR2A—attention deficit hyperactivity disorder	3.68e-05	0.00338	CrCbGaD
Prochlorperazine—Loxapine—HTR2A—attention deficit hyperactivity disorder	3.65e-05	0.00336	CrCbGaD
Prochlorperazine—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.64e-05	0.000251	CbGpPWpGaD
Prochlorperazine—Perphenazine—HTR2A—attention deficit hyperactivity disorder	3.64e-05	0.00335	CrCbGaD
Prochlorperazine—Quetiapine—HTR2A—attention deficit hyperactivity disorder	3.57e-05	0.00328	CrCbGaD
Prochlorperazine—DRD3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.54e-05	0.000244	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.45e-05	0.000238	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.39e-05	0.000234	CbGpPWpGaD
Prochlorperazine—Desipramine—HTR2A—attention deficit hyperactivity disorder	3.38e-05	0.00312	CrCbGaD
Prochlorperazine—DRD3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.33e-05	0.00023	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.3e-05	0.000228	CbGpPWpGaD
Prochlorperazine—Promazine—HTR2A—attention deficit hyperactivity disorder	3.28e-05	0.00302	CrCbGaD
Prochlorperazine—DRD3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.22e-05	0.000222	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.1e-05	0.000213	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.07e-05	0.000212	CbGpPWpGaD
Prochlorperazine—Clozapine—HTR2A—attention deficit hyperactivity disorder	3.07e-05	0.00282	CrCbGaD
Prochlorperazine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3e-05	0.000207	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.95e-05	0.000203	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.92e-05	0.000201	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.91e-05	0.000201	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.89e-05	0.000199	CbGpPWpGaD
Prochlorperazine—Chlorpromazine—HTR2A—attention deficit hyperactivity disorder	2.88e-05	0.00266	CrCbGaD
Prochlorperazine—Imipramine—HTR2A—attention deficit hyperactivity disorder	2.87e-05	0.00264	CrCbGaD
Prochlorperazine—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.86e-05	0.000197	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.82e-05	0.000194	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.79e-05	0.000192	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.71e-05	0.000187	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.71e-05	0.000187	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.69e-05	0.000185	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.66e-05	0.000183	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.62e-05	0.00018	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.6e-05	0.000179	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.56e-05	0.000176	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.55e-05	0.000176	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.52e-05	0.000174	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.5e-05	0.000173	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.46e-05	0.00017	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.46e-05	0.00017	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.42e-05	0.000167	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.38e-05	0.000164	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.37e-05	0.000163	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.35e-05	0.000162	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.33e-05	0.00016	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.29e-05	0.000158	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.29e-05	0.000158	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.26e-05	0.000156	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.25e-05	0.000155	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.23e-05	0.000154	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.22e-05	0.000153	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.21e-05	0.000153	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.19e-05	0.000151	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.18e-05	0.00015	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.15e-05	0.000148	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	2.07e-05	0.000143	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.07e-05	0.000143	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.04e-05	0.00014	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	2.03e-05	0.00014	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.01e-05	0.000138	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.96e-05	0.000135	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.9e-05	0.000131	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.89e-05	0.00013	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.65e-05	0.000114	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.65e-05	0.000114	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.57e-05	0.000108	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.45e-05	0.0001	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.43e-05	9.84e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.4e-05	9.68e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	1.35e-05	9.32e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.35e-05	9.32e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	1.33e-05	9.17e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	1.25e-05	8.64e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	1.24e-05	8.58e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.24e-05	8.52e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.08e-05	7.45e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.03e-05	7.09e-05	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.01e-05	6.94e-05	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.73e-06	6.02e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	8.19e-06	5.65e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	8.13e-06	5.61e-05	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.7e-06	5.31e-05	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.56e-06	5.21e-05	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.44e-06	5.13e-05	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	5.37e-06	3.7e-05	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	3.51e-06	2.42e-05	CbGpPWpGaD
